Why Cara Therapeutics Is One of Wednesday’s Big Winners
Cara Therapeutics shares jumped on Wednesday after the firm announced a key update in its late-stage chronic kidney disease trial.
All Work
Chris Lange
Meet Activision Blizzard’s ‘New’ CFO
Activision Blizzard shares dipped on Wednesday after the firm announced that it would be making a change in its top-level leadership.
TCR2 Therapeutics Files for IPO
Immunotherapy company TCR2 Therapeutics has filed with the SEC regarding its initial public offering.
Wells Fargo to Pay $575 Million to Resolve Civil Claims
Wells Fargo shares were up slightly on Friday despite the megabank announcing that it would make a massive payment to resolve civil claims that it had created phony accounts and other customer abuses.
Can This Weight Watchers Deal Save Blue Apron?
Blue Apron shares popped this week following news of a new deal with Weight Watchers International that some believe could save this struggling meal kit delivery service.
Did Energous Just Lock In Success of Wireless Charging for 2019?
Energous shares pulled back a little on Friday after making an absolutely massive run on Thursday. Despite the recent gains, the stock is still sharply down for the year.
Opko Settles Fraud Charges With SEC: Good News for Investors?
Opko Health shares shot up on Friday after the firm announced that it has settled with the SEC with regard to charges against the company's CEO.
Harpoon Therapeutics Files for IPO
Clinical-stage immunotherapy company Harpoon Therapeutics has filed with the SEC for its initial public offering.
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a positive day for the broad U.S. markets. Each of the major exchanges started out the day on a negative note, but as the session went on markets moved higher. Crude oil…
Why Citron Changed Its Mind on Facebook
Facebook shares dipped on Thursday following a recent report from the infamous short-selling firm Citron Research in which it seemed to be changing its tune.
Is Spectrum Pharma’s FDA Update Good News for Breast Cancer Patients?
Spectrum Pharma shares dipped on Thursday after the firm announced a key update from the FDA on its treatment of neutropenia in breast cancer patients.
Short Sellers Grow More Selective in Major Oil Stocks
The December 14 short interest data have been compared with the previous figures, and short interest in these selected big oil stocks was mixed.
Social Media Stocks Feel Short Interest Sting
The December 14 short interest data have been compared with the previous report. Short interest in most of these selected social media stocks increased for this settlement date.
Short Sellers Hike Bets in Major Pharma Stocks
The December 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Major Semiconductor Stocks See Mixed Short Report
The December 14 short interest data have been compared with the previous report. Short interest moves in these selected semiconductor stocks were mixed.
Where Short Interest in Cybersecurity Stocks Has Gone
The December 14 short interest data have been compared with the previous figures, and short interest moves in these selected cybersecurity stocks were mixed.
Big Bank Short Interest Affirms Bear Market
The December 14 short interest data have been compared with the previous figures, and short interest in these selected big bank stocks increased.
Short Sellers Can’t Make Up Their Minds on Major Biotechs
The December 14 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Should CarMax Get More Credit for Q3 Earnings?
CarMax released mixed fiscal third-quarter financial results before the markets opened on Friday, but its share price rose.
Zynga Moves to Acquire European Game Studio
Zynga shares made a handy gain on Friday after the firm announced that it would be acquiring a European game studio. The transaction is expected to close effective as of January 1, 2019.